Product
HA
1 clinical trial
1 indication
Indication
Pancreatic Ductal AdenocarcinomaClinical trial
A Window-of-Opportunity Trial Using Neoadjuvant Hepatic Artery Chemotherapy for Patients With Localized Pancreas CancerStatus: Recruiting, Estimated PCD: 2025-04-30